Legal Opinion
Intendis Gmbh v. Glenmark Pharmaceuticals Inc.
Court of Appeals for the Federal Circuit
Decided May 16, 2016No. 2015-1902PublishedCited by 36 opinions
1Opinion of the Court
MOORE, Circuit Judge.
This case arises under the Hatch-Waxman Act, 1 and involves Glenmark Pharmaceuticals Ltd. and Glenmark Pharmaceuticals Inc., USA’s (collectively, “Glenmark”) 2 proposed generic version of Finacea® Gel, a topical medication for various skin disorders. Glenmark appeals the United States District Court for the District of Delaware’s final judgment entered in favor of Intendis GmbH, Intraserv GmbH & Co. KG, and Bayer Healthcare Pharmaceuticals Inc. (collectively, “Appellees”). For the reasons set forth below, we affirm.
BACKGROUND
Appellee Bayer Healthcare Pharmaceuticals Inc.…
2Cases cited13 opinions
- Graver Tank & Mfg. Co. v. Linde Air Products Co.Supreme Court of the United States · 1950
- Warner-Jenkinson Co. v. Hilton Davis Chemical Co.Supreme Court of the United States · 1997
- Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.Supreme Court of the United States · 2002
- Conoco, Inc. v. Energy & Environmental International, L.C.Court of Appeals for the Federal Circuit · 2006
- DePuy Spine, Inc. v. Medtronic Sofamor Danek, Inc.Court of Appeals for the Federal Circuit · 2009
8 more not listed; retrieve them via the Exa API.
3Cited by36 opinions
- Power Integrations, Inc. v. Fairchild Semiconductor Int'l, Inc.Court of Appeals for the Federal Circuit · 2018
- Ucb, Inc. v. Watson Laboratories Inc.Court of Appeals for the Federal Circuit · 2019
- Impax Laboratories Inc. v. Lannett Holdings Inc.Court of Appeals for the Federal Circuit · 2018
- Jang v. Boston Scientific CorporationCourt of Appeals for the Federal Circuit · 2017
- Wright's Well Control Servs., LLC v. Oceaneering Int'l, Inc.District Court, E.D. Louisiana · 2018
31 more not listed; retrieve them via the Exa API.